Perhexiline maleate Datasheet DC Chemicals
Target Home > Products > Featured products
Cat.No DC21821
Name Perhexiline maleate

Chemical Properties

CAS 6724-53-4
Formula C23H39NO4
MW 393.560067415237
Storage 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological activity

Description CAS NO.:6724-53-4
Product Name:PERHEXILINE MALEATE
Synonyms:PERHEXILINE MALEATE ;rac Perhexiline Maleate;(Z)-but-2-enedioic acid,2-(2,2-dicyclohexylethyl)piperidine;PERHEXILINE MALEATE;PERHEXILINE MALEATE SALT;rac Perhexiline Male;2-(2,2-Dicyclohexylethyl)piperidine maleate;DSSTox_CID_1114;EINECS 229-775-5;perhexilene maleate;Perhexiline maleate (USAN);perhexilline maleate;Pexid;2-(2,2-Dicyclohexylethyl)piperidine
EINEC:
Molecular Formula:C23H39NO4
Molecular Weight:393.560067415237
Target: IC50: 77 μM (Rat heart CPT 1), 148 μM (Rat liver CPT 1)[1]
In Vivo The co-administration of Perhexiline and cisplatin yields a clear enhancement of antitumor effects, resulting in a significantly improved progression-free survival as compared with mice treated with DMSO. Perhexiline favors NB cell transition to differentiated phenotype[2].
In Vitro At 24, 48 and 72 h of treatment with 0.01 and 1 μM of Perhexiline , NDM29 ncRNA expression level in SH-SY5Y cells is progressively increased, reaching a peak after 48 hours of treatment. Perhexiline treatment increases the susceptibility of NB cells to antiblastic treatments. Co-administration of Perhexiline maleate potentiates the efficacy of cisplatin to reduce the in vitro clonogenic potential of NB cells[2].
Kinase Assay
Cell Assay The effect of antitumoral drugs on neuroblastoma cell survival is evaluated using the MTT assay. Approximately 24 hours after plating, cells are exposed to Perhexiline maleate (0.01 μM) for 48 hours at 37°C. Cytotoxicity is expressed as the percentage of cells surviving in relation to untreated cells[2].
Animal Administration Mice: In protocol a, 21 mice are divided in 4 groups: control vehicle group: DMSO; cisplatin (3 mg/kg/dose) treated group; Perhexiline (1 mg/kg/dose) treated group and; Perhexiline (1 mg/kg/dose) and cisplatin (3 mg/kg/dose) treated group. In protocol b, 20 mice are divided in 4 groups: control vehicle group: DMSO; Perhexiline (3 mg/kg/dose) treated group; cisplatin (5 mg/kg/dose) treated group; Perhexiline (3 mg/kg/dose) and cisplatin (5 mg/kg/dose) treated group[2].

References

[1]. Kennedy JA, et al. Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by Perhexiline and amiodarone. Biochem Pharmacol. 1996 Jul 26;52(2):273-80. [2]. Vella S, et al. Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA. Sci Rep. 2015 Dec 17;5:18144.
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131
Fax: +86-21-61642470

Email:
sales@dcchemicals.com
order@dcchemicals.com

Website:
www.dcchemicals.com